{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T01:11:50Z","timestamp":1772500310730,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100025224","name":"Iowa Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100025224","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.japh.2024.102213","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T06:00:16Z","timestamp":1724047216000},"page":"102213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Borne of necessity: Pharmacy-based harm reduction and express sexually transmitted infection services"],"prefix":"10.1016","volume":"64","author":[{"given":"Whitney","family":"Dickson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7982-8477","authenticated-orcid":false,"given":"Jinny","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Leston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7547-484X","authenticated-orcid":false,"given":"Brigg","family":"Reilley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.japh.2024.102213_bib1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and geographic patterns in drug and synthetic opioid overdose deaths\u2014United States, 2013\u20132019","volume":"70","author":"Mattson","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"50","key":"10.1016\/j.japh.2024.102213_bib2","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.15585\/mmwr.mm7050e3","article-title":"Trends in and characteristics of drug overdose deaths involving illicitly manufactured fentanyls\u2014United States, 2019\u20132020","volume":"70","author":"O\u2019Donnell","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"14","key":"10.1016\/j.japh.2024.102213_bib13","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMp1613899","article-title":"And how long will you be staying, doctor?","volume":"376","author":"Kovich","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.japh.2024.102213_bib14","article-title":"A\u00a0regional analysis of hepatitis C virus collaborative care with pharmacists in Indian Health Service facilities","volume":"9","author":"Geiger","year":"2018","journal-title":"J\u00a0Prim Care Community Health"},{"issue":"3","key":"10.1016\/j.japh.2024.102213_bib17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3821\/145.3.cpj124","article-title":"Pharmacists and harm reduction: a review of current practices and attitudes","volume":"145","author":"Watson","year":"2012","journal-title":"Can. Pharm. J. (Ott)"},{"issue":"1","key":"10.1016\/j.japh.2024.102213_bib18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13722-019-0158-0","article-title":"Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders","volume":"14","author":"Bach","year":"2019","journal-title":"Addict Sci Clin Pract"},{"issue":"4","key":"10.1016\/j.japh.2024.102213_bib19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/08897077.2019.1694618","article-title":"Pharmacy: addressing substance use in the 21st century","volume":"40","author":"Bratberg","year":"2019","journal-title":"Subst Abus"},{"issue":"1","key":"10.1016\/j.japh.2024.102213_bib21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12889-017-4210-2","article-title":"Effectiveness of needle and syringe programmes in people who inject drugs \u2013 an overview of systematic reviews","volume":"17","author":"Fernandes","year":"2017","journal-title":"BMC Public Health"},{"issue":"9","key":"10.1016\/j.japh.2024.102213_bib22","article-title":"Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs","volume":"9","author":"Platt","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.japh.2024.102213_bib27","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2471\/BLT.17.191635","article-title":"Monetary incentives for provision of syphilis screening, Yunnan, China","volume":"95","author":"Zhang","year":"2017","journal-title":"Bull World Health Organ"},{"issue":"2 suppl 1","key":"10.1016\/j.japh.2024.102213_bib28","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1097\/OLQ.0000000000000294","article-title":"Interventions to improve sexually transmitted disease screening in clinic-based settings","volume":"43","author":"Taylor","year":"2016","journal-title":"Sex Transm Dis"},{"issue":"2","key":"10.1016\/j.japh.2024.102213_bib29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0749-3797(00)00283-X","article-title":"Incentives vs outreach workers for latent tuberculosis treatment in drug users","volume":"20","author":"Malotte","year":"2001","journal-title":"Am J Prev Med"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124002395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124002395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T02:08:20Z","timestamp":1736302100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319124002395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1544319124002395"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2024.102213","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Borne of necessity: Pharmacy-based harm reduction and express sexually transmitted infection services","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2024.102213","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102213"}}